|
一、项目概况：
1、主要产品及生产规模：年产500万盒“双士再生精”口服液
2、产品特点：该产品主要采用鹿茸、长白山野生大蚂蚁、黄芪等为主要原料，配以其它中草药经现代科学方法制成的纯中药口服液，已于1994年8月获得吉林省卫生厅批准的生 产文号。该产品特点：不含防腐剂，主要是采用食用酒防腐，避免了防腐剂对人体的危害，同时患者在服用本产品时酒起到引药归经、全面治疗的作用。该产品主要功能是增加肾的营养，补充肾精气，调节内分泌，提高肾功能，改善微循环，促进新陈代谢，使肌体细胞不断再生更新，肾功能得到恢复，激发各器官各组织的活力，从而治疗肾虚症状和肾虚所致疾病，达到抗衰老的目的。
3、技术水平：“双士再生精”口服液，是由本公司总经理安继财发明研制的，并结合工程技术人员制药经验，根据国内先进技术和中药传统工艺、现代科学方法制定的工艺技术标准和产品质量标准。工艺技术成熟，产品质量稳定，患者反映疗效好，通过吉林省卫生厅新药审评办、专家委员会鉴定，经卫生厅国家药监局批准为新产品，国家专利产品。
4、项目市场情况分析：“双士再生精”口服液产品自1995年投产以来，由于与同类产品相比配方独特、工艺新、疗效好、价格低，产品投产后供不应求，产值、利润逐年上升。公司为进一步扩大生产、提高产品质量，准备实施年产500万盒“双士再生精”GMP改造项目。
5、投资总额：500万美元
6、占地面积：土地10,000平方米，建设5,000平方米的厂房。其中GMP标准厂房3,000平方米。
7、中外方投资比例：外方：245万美元，占49%投资构成：资金、设备
中方：255万美元，占51%投资构成：资金、土地、厂房
8、合作方式：合资
9、经济效益分析：销售收入：1250万美元年利润：360万美元
税金：200万美元投资回收期2.5年
10、拟建项目选址：吉林高新技术产业开发区内新建
11、项目进展情况：吉林高新区立项，可行研究报告完成。
二、中方企业情况：
1、企业名称：吉林市乾坤药业公司
2、企业基本情况：注册资金25万美元，固定资产，75万美元，职工60人，其中科技人员18人。
公司于1994年成立，隶属于吉林市医药化工管理局。公司为吉林省科委认定的高新技术企业。
3、主要产品及规模：年产100万盒“双士再生精”口服液。
三、联系方式：
单位：吉林市江城网站
联系人：马天作
手机：013514426560
地址：吉林市北京路142号
邮编：132011
电话：86-432-2014042、2014043
传真：86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
GMP Innovation Project of Shuangshi Self-born Liquid
1. Description of the proposed project
1-1. Main product and scale of production: Annual output 5 million boxes of Shuangshi self-born liquid.
1-2. Characteristics of the product: The mail raw material of this product include: deer antler, wild big ant from Changbai mountain, and tragacanth. It’s a kind of Chinese medicine without anti-corrodent. This product is really effective in improving people’s health.
1-3. Technical level: Shuangshi self-born liquid, invented by manager An Jicai, is the company’s main product. It’s a high-tech product achieving the national patent. With its mature technology, stable quality and clear and significant curative effects, this product is well acknowledged by the customers.
1-4. Market status: First manufactured in 1995, this product is well acknowledged by the customers due to its mature technology, stable quality and clear and significant curative effects. In order to expand the production scale, the company that invents this product wants to construct the GMP Innovation Project of Shuangshi self-born liquid.
1-5. Total investment: US$ 5 million
1-6. Land coverage: 10,000 square meters; plant premises: 5,000 square meters, inclusive of 3,000 square meters GMP plants.
1-7. Proposed ownership structure: foreign partner: US$ 2.45 million, 49%, by cash and facilities,
Chinese partner US$ 2.55 million, 51%, by cash, land and plants.
1-8. Form of cooperation: joint venture.
1-9. Economic benefit analysis: Annual sales will US$ 12.5 million, annual profit will be US$ 3.6 million, annual tax will be US$ 2 million, payback period will be 2.5 years.
1-10. Project site: Jilin Hi-tech Industrial Development Zone.
1-11. Proceeding of the project: Approval report of Jilin Hi-tech Zone and feasibility study report are completed.
2. Description of Chinese partner
2-1. Company name: Jilin City Qiankun Pharmaceutical Company Limited
2-2. Company data: registered capital is US$ 250 thousand, fixed assets is US$ 750 thousand, number of staff and workers is 60, including 18 technicians. The company has been approved as Hi-tech enterprise by the Science and Technology Committee of Jilin Province.
2-3. Main product: Shuangshi self-born liquid.
3. Contact mode
Company: JiLin City JiangCheng Network
Name: Ma Tianzuo
Mobile: 013514426560
Address: No.142 BeiJing Road in JiLin City
P.C.: 132013
Tel: 86-432- 2014042、2014043
Fax: 86-432-2014044
Http://www.jiangcheng.net
E-mail: web@jiangcheng.net
| 
